Viewing Study NCT01593527


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2025-12-26 @ 4:10 AM
Study NCT ID: NCT01593527
Status: WITHDRAWN
Last Update Posted: 2017-04-20
First Post: 2012-05-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-09
Start Date Type: None
Primary Completion Date: 2012-09
Primary Completion Date Type: ESTIMATED
Completion Date: 2012-09
Completion Date Type: ESTIMATED
First Submit Date: 2012-05-03
First Submit QC Date: None
Study First Post Date: 2012-05-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-04-19
Last Update Post Date: 2017-04-20
Last Update Post Date Type: ACTUAL